Company / Current Assets
PTC Therapeutics, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$2.3B
FY2025
5-year range
$693.8M / $2.3B
FY2021-FY2025
Trend
+66.5%
vs FY2024
Sector context
#29 of 213
Health Care
What the data says
PTC Therapeutics, Inc.'s current assets of $2.3B is higher than 86% of companies in the Health Care sector (FY2025). Current Assets has increased for 3 consecutive years, from $694M in FY2022 to $2.3B in FY2025.
Based on SEC 10-K filings.
$2.3B in FY2025 with a 5-year CAGR of +13.0%. Top quartile in the Health Care sector.
Improved from $1.2B to $2.3B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +48.5%
- 5-Year CAGR
- +13.0%
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 213This company $2.3B Sector average $2.5B
▼
-9.9% below sector average
Key checks
Key Insights
- PTC Therapeutics, Inc.'s current assets has grown for 3 consecutive years.
- 5-year CAGR of +13.0%, indicating consistent growth.
- In FY2025, current assets increased 66.5% year-over-year.
- Ranks #29 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.3B | +66.5% |
| FY2024 | $1.4B | +12.1% |
| FY2023 | $1.2B | +75.6% |
| FY2022 | $693.8M | -27.3% |
| FY2021 | $954.4M | -22.5% |
| FY2020 | $1.2B | +58.1% |
| FY2019 | $779.3M | +142.9% |
| FY2018 | $320.9M | +28.8% |
| FY2017 | $249.1M | -4.7% |
| FY2016 | $261.3M | -26.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026